Clinical Trials Logo
  1. Home
  2. Venous Thromboembolism
  3. NCT00201903
  4. Details
NCT00201903 Clinical Trial

The Roles of Tissue Factor in Malignant Gliomas

Venous Thromboembolism Clinical Trial

Official title:
The Roles of Tissue Factor in Malignant Gliomas

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00201903
Other study ID # OCOG-2003-TFsubstudy
Secondary ID
Status Completed
Phase N/A
First received September 13, 2005
Last updated April 5, 2017
Start date January 2004
Est. completion date October 2006

Study information
Verified date May 2007
Source Ontario Clinical Oncology Group (OCOG)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma

Description:

To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma

Recruitment information / eligibility
Status Completed
Enrollment 30
Est. completion date October 2006
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- participation in PRODIGE

- adult patients

- newly diagnosed, biopsy-confirmed grade III/IV malignant gliomas

- undergone craniotomy or stereotactic biopsy > 2 days and < 4 weeks before

Exclusion Criteria:

- have known hereditary thrombophilia

- are receiving experimental antiangiogenic therapy

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Canada Cross Cancer Institute Edmonton Alberta
Canada Princess Margaret Hospital Toronto Ontario
Canada Toronto-Sunnybrook Regional Cancer Centre Toronto Ontario
Canada CancerCare Manitoba Winnipeg Manitoba
United States Henry Ford Hospital Detroit Michigan
United States Huntsman Cancer Institute Salt Lake City Utah

Sponsors (2)
Lead Sponsor Collaborator
Ontario Clinical Oncology Group (OCOG) Ontario Cancer Research Network

Countries where clinical trial is conducted

United States,  Canada, 

See also
  Status Clinical Trial Phase
Recruiting NCT05347550 - Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients N/A
Enrolling by invitation NCT05794165 - Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism Phase 2
Completed NCT02379806 - The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study Phase 3
Recruiting NCT03691753 - Safety and Efficacy Study of Fitaya Vena Cava Filter N/A
Completed NCT02197416 - Safety of Dabigatran Etexilate in Blood Clot Prevention in Children Phase 3
Recruiting NCT05378035 - DOAC in Chinese Patients With Atrial Fibrillation
Recruiting NCT05171075 - A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE Phase 3
Completed NCT01895777 - Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) Phase 3
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Completed NCT04736719 - Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data
Completed NCT04736420 - Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
Completed NCT04735523 - Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data
Completed NCT02912234 - Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants Phase 1
Completed NCT02746185 - Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban Phase 3
Completed NCT02829957 - RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding Phase 2/Phase 3
Completed NCT02334007 - Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery Phase 1/Phase 2
Completed NCT02223260 - Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age Phase 2
Completed NCT02661568 - Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES) N/A
Completed NCT01976988 - Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery Phase 3
Completed NCT01972243 - Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model